Amlodipine and Atorvastatin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
46708-765 -
Package NDC
46708-765-30 -
Package NDC
46708-765-90 -
Application number
ANDA217279 -
SPL ID
ecab983e-6ed8-4440-b7b4-7ac4bf39b26c -
SPL set ID
ecab983e-6ed8-4440-b7b4-7ac4bf39b26c -
UNII
864V2Q084H -
UNII
48A5M73Z4Q -
RxCUI
404011 -
RxCUI
404013 -
RxCUI
597967 -
RxCUI
597971 -
RxCUI
597974 -
RxCUI
597977 -
RxCUI
597980 -
RxCUI
597984 -
RxCUI
597987 -
RxCUI
597990 -
RxCUI
597993
What the source publishes
- Labeler
- Alembic Pharmaceuticals Limited
- Active ingredients
- Amlodipine and Atorvastatin
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Amlodipine and Atorvastatin",
"splId": "ecab983e-6ed8-4440-b7b4-7ac4bf39b26c",
"labels": [
{
"setId": "ecab983e-6ed8-4440-b7b4-7ac4bf39b26c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ecab983e-6ed8-4440-b7b4-7ac4bf39b26c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ecab983e-6ed8-4440-b7b4-7ac4bf39b26c"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (46708-765-30)",
"package_ndc": "46708-765-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250523"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (46708-765-90)",
"package_ndc": "46708-765-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20250523"
}
],
"productId": "46708-765_ecab983e-6ed8-4440-b7b4-7ac4bf39b26c",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "46708-765",
"deaSchedule": null,
"genericName": "Amlodipine and Atorvastatin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMLODIPINE BESYLATE",
"strength": "10 mg/1"
},
{
"name": "ATORVASTATIN CALCIUM TRIHYDRATE",
"strength": "80 mg/1"
}
],
"applicationNumber": "ANDA217279",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250523",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"864V2Q084H",
"48A5M73Z4Q"
],
"rxcui": [
"404011",
"404013",
"597967",
"597971",
"597974",
"597977",
"597980",
"597984",
"597987",
"597990",
"597993"
],
"spl_set_id": [
"ecab983e-6ed8-4440-b7b4-7ac4bf39b26c"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:46708-765_ecab983e-6ed8-4440-b7b4-7ac4bf39b26c"